InnoCare Pharma
68842827.390.55% ( +0.15 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: InnoCare Pharma(688428) predict that the Revenue is 528.63 M (+38.65%), Miss estimate;the EBIT is 68.56 M (--%), Beat estimate;the EPS is 0.06 (--%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.53B38.65%
0.65B71.56%
-0.13B32.91%
EBITExceed expectations
0.07B--
-0.03B--
+0.10B--%
EPSExceed expectations
0.06--
0--
+0.0600--%
Upcoming earnings report - FY2026 Semi-Annual Earning Release
Available dateAug 25, 2026
Estimate Revenue1.214 B
Estimate EBIT100.69 M
Estimate EPS--
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf